IG
Invus Global Management, LLC cut its SLN stake below 5%
Invus Global Management, LLC reported owning 4.6% of Silence Therapeutics plc (SLN) (8,663,601 shares) in a Schedule 13G filed Nov 12, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 12, 2026
- Source
- Schedule 13G